Traws Pharma Inc TRAW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:49 AM EDT
0.668quote price arrow up+0.008 (+1.2121%)
Volume
13,295
52 week range
0.55 - 1.45
Loading...
  • Open0.6488
  • Day High0.669
  • Day Low0.64
  • Prev Close0.66
  • 52 Week High1.45
  • 52 Week High Date05/08/23
  • 52 Week Low0.55
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap16.901M
  • Shares Out25.30M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-10.41

KEY STATS

  • Open0.6488
  • Day High0.669
  • Day Low0.64
  • Prev Close0.66
  • 52 Week High1.45
  • 52 Week High Date05/08/23
  • 52 Week Low0.55
  • 52 Week Low Date10/13/23
  • Market Cap16.901M
  • Shares Out25.30M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change-10.41

RATIOS/PROFITABILITY

  • EPS (TTM)-0.90
  • P/E (TTM)-0.74
  • Fwd P/E (NTM)-0.66
  • EBITDA (TTM)-20.282M
  • ROE (TTM)-97.22%
  • Revenue (TTM)225,999.996
  • Gross Margin (TTM)-
  • Net Margin (TTM)-8,384.07%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Traws Pharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a Mpro protease inhibitor for COVID19. Narazaciclib is a cyclin-dependent kinases...
Iain Dukes Ph.D.
Executive Chairman of the Board
Werner Cautreels
Chief Executive Officer, Director
Steven Fruchtman M.D.
President
Nikolay Savchuk Ph.D.
Chief Operating Officer, Director
Address
12 Penns Trail
Newtown, PA
18940
United States

Top Peers

SYMBOLLASTCHG%CHG
COCP
Cocrystal Pharma Inc
1.56+0.01+0.61%
OTLC
Oncotelic Therapeutics Inc
0.0388-0.0012-2.8786%
ALZN
Alzamend Neuro Inc
0.71-0.001-0.1406%
NERV
Minerva Neurosciences Inc
2.36UNCHUNCH
VINC
Vincerx Pharma Inc
0.8603+0.0333+4.0266%